162 related articles for article (PubMed ID: 33108684)
21. Genetics, Diagnosis, and Management of Hürthle Cell Thyroid Neoplasms.
McFadden DG; Sadow PM
Front Endocrinol (Lausanne); 2021; 12():696386. PubMed ID: 34177816
[TBL] [Abstract][Full Text] [Related]
22. Polymerase chain reaction-based microsatellite polymorphism analysis of follicular and Hürthle cell neoplasms of the thyroid.
Segev DL; Saji M; Phillips GS; Westra WH; Takiyama Y; Piantadosi S; Smallridge RC; Nishiyama RH; Udelsman R; Zeiger MA
J Clin Endocrinol Metab; 1998 Jun; 83(6):2036-42. PubMed ID: 9626136
[TBL] [Abstract][Full Text] [Related]
23. Biological differential diagnosis of follicular thyroid tumor and Hürthle cell tumor on the basis of telomere length and hTERT expression.
Sugishita Y; Kammori M; Yamada O; Yamazaki K; Ito K; Fukumori T; Yoshikawa K; Yamada T
Ann Surg Oncol; 2014 Jul; 21(7):2318-25. PubMed ID: 24562933
[TBL] [Abstract][Full Text] [Related]
24. Malignancy risk for solitary and multiple nodules in Hürthle cell-predominant thyroid fine-needle aspirations: A multi-institutional study.
Wong KS; Jo VY; Lowe AC; Faquin WC; Renshaw AA; Shah AA; Roh MH; Stelow EB; Krane JF
Cancer Cytopathol; 2020 Jan; 128(1):68-75. PubMed ID: 31751003
[TBL] [Abstract][Full Text] [Related]
25. Use of a thin-layer technique in thyroid fine needle aspiration.
Malle D; Valeri RM; Pazaitou-Panajiotou K; Kiziridou A; Vainas I; Destouni C
Acta Cytol; 2006; 50(1):23-7. PubMed ID: 16514836
[TBL] [Abstract][Full Text] [Related]
26. The Presence of Hürthle Cells Does Not Increase the Risk of Malignancy in Most Bethesda Categories in Thyroid Fine-Needle Aspirates.
Ren Y; Kyriazidis N; Faquin WC; Soylu S; Kamani D; Saade R; Torchia N; Lubitz C; Davies L; Stathatos N; Stephen AE; Randolph GW
Thyroid; 2020 Mar; 30(3):425-431. PubMed ID: 32013786
[No Abstract] [Full Text] [Related]
27. Cytomorphologic Spectrum of Hurthle Cell Lesions of Thyroid: A Study of 54 Cases.
Anila KR; Nayak N; George PS; Jayasree K
Gulf J Oncolog; 2018 Jan; 1(26):6-10. PubMed ID: 29607815
[TBL] [Abstract][Full Text] [Related]
28. Fine-needle aspiration cytology of Hürthle cell carcinoma of the thyroid.
Wu HH; Clouse J; Ren R
Diagn Cytopathol; 2008 Mar; 36(3):149-54. PubMed ID: 18232004
[TBL] [Abstract][Full Text] [Related]
29. Medullary carcinoma of thyroid mimicking Hurthle cell neoplasm on cytology: a diagnostic dilemma.
Agarwal C; Raychaudhuri S; Batra A; Pujani M; Dhingra S
Diagn Cytopathol; 2019 Sep; 47(9):943-947. PubMed ID: 31190466
[TBL] [Abstract][Full Text] [Related]
30. Hurthle cell tumor of the thyroid gland: report of a rare case and review of literature.
Okere PC; Olusina DB; Enyinnah MO
Niger J Clin Pract; 2014; 17(3):375-7. PubMed ID: 24714021
[TBL] [Abstract][Full Text] [Related]
31. The role of molecular testing in the diagnosis of medullary thyroid cancer: A case report of oncocytic medullary thyroid carcinoma and review of the literature.
Spaulding SL; Ho R; Everest S; Chai RL
Am J Otolaryngol; 2020; 41(1):102312. PubMed ID: 31727331
[TBL] [Abstract][Full Text] [Related]
32. Can abundant colloid exclude oncocytic (Hürthle cell) carcinoma in thyroid fine needle aspiration? Cytohistological correlation of 127 oncocytic (Hürthle cell) lesions.
Yang GC; Schreiner AM; Sun W
Cytopathology; 2013 Jun; 24(3):185-93. PubMed ID: 22672530
[TBL] [Abstract][Full Text] [Related]
33. EIF1AX Mutation in a Patient with Hürthle Cell Carcinoma.
Topf MC; Wang ZX; Furlong K; Miller JL; Tuluc M; Pribitkin EA
Endocr Pathol; 2018 Mar; 29(1):27-29. PubMed ID: 28965201
[TBL] [Abstract][Full Text] [Related]
34. Mitochondrial DNA "common deletion" in post-fine needle aspiration infarcted oncocytic thyroid tumors.
Conti L; Vatrano S; Bertero L; Masu L; Pacchioni D; Daniele L; De Rosa G; Cassoni P; Volante M; Papotti M
Hum Pathol; 2017 Nov; 69():23-30. PubMed ID: 28962946
[TBL] [Abstract][Full Text] [Related]
35. Preoperative diagnostic categories of fine needle aspiration cytology for histologically proven thyroid follicular adenoma and carcinoma, and Hurthle cell adenoma and carcinoma: Analysis of cause of under- or misdiagnoses.
Na HY; Moon JH; Choi JY; Yu HW; Jeong WJ; Kim YK; Choe JY; Park SY
PLoS One; 2020; 15(11):e0241597. PubMed ID: 33147258
[TBL] [Abstract][Full Text] [Related]
36. Granular cell tumor of thyroid: a case series with molecular characterization highlighting unique pitfalls.
Srivastava P; Da Cruz Paula A; Weigelt B; Pareja F; Reis-Filho JS; Yip L; Pantanowitz L; Seethala RR
Endocrine; 2022 May; 76(2):395-406. PubMed ID: 35175560
[TBL] [Abstract][Full Text] [Related]
37. Cytology of "clear cell" variant of oncocytic/Hürthle cell carcinoma of the thyroid.
Sturgis CD; Chang HS; Boudousquie AC
Diagn Cytopathol; 2011 Aug; 39(8):595-7. PubMed ID: 21761577
[No Abstract] [Full Text] [Related]
38. [Nodule diagnosed as follicular patterned lesion: are biomarkers the promise?].
Cerutti JM
Arq Bras Endocrinol Metabol; 2007 Jul; 51(5):832-42. PubMed ID: 17891248
[TBL] [Abstract][Full Text] [Related]
39. Fine needle aspiration of poorly differentiated oxyphilic (Hürthle cell) thyroid carcinoma: a case report.
Ghofrani M; Sosa JA; Ocal IT; Angeletti C
Acta Cytol; 2006; 50(5):560-2. PubMed ID: 17017447
[TBL] [Abstract][Full Text] [Related]
40. Expression of cytokeratin 19 in the diagnosis of thyroid papillary carcinoma by quantitative polymerase chain reaction.
Flanagan JN; Pineda P; Knapp PE; De Las Morenas A; Lee SL; Braverman LE
Endocr Pract; 2008 Mar; 14(2):168-74. PubMed ID: 18308654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
